4Filing Date: Sep 2, 2026

RxSight (RXST)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001193125-26-380714
Total Value$35.5K
Trades4
Insiders1

Transaction Details

Kurtz Ronald M MD
Chief Medical Officer·Direct
Sell · Dispose
Common Stock
Shares-5.10K
Price$6.96
Total Value$35.5K
Shares Owned After71.78K
Transaction DateSep 2, 2026
Footnotes ▸

Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person.

Kurtz Ronald M MD
Chief Medical Officer·Direct
Exercise · Acquire
Common Stock
Shares+13.43K
Price-
Total Value$0
Shares Owned After76.88K
Transaction DateAug 31, 2026
Footnotes ▸

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Kurtz Ronald M MD
Chief Medical Officer·Direct
Exercise · Dispose
Restricted Stock UnitDerivative
Shares-13.43K
Price$0.00
Total Value$0
Shares Owned After67.12K
Transaction DateAug 31, 2026
Footnotes ▸

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029.

Kurtz Ronald M MD
Chief Medical Officer·Indirect · See footnote
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After764.61K
Footnotes ▸

Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.

Post-Transaction Holdings

Kurtz Ronald M MD · Chief Medical Officer
SecuritySharesChange
Common Stock836.38K+8.32K (1.01%)
Restricted Stock Unit67.12K-13.43K (-16.67%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-31 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: RxSight, Inc. (RXST) CIK: 0001111485 --- Reporting Owner --- Name: Kurtz Ronald M MD CIK: 0001295469 Role: Officer (Chief Medical Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-31 | Code: M (Exercise of derivative) Shares: +13,425 Shares Owned After: 76,875 | Ownership: D (Direct) Footnotes: [F1] Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. [Transaction #2] Security: Common Stock Date: 2026-09-02 | Code: S (Open market sale) Shares: -5,100 | Price: $6.96 Total Value: $35,496.00 Shares Owned After: 71,775 | Ownership: D (Direct) Footnotes: [F2] Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person. --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Unit Date: 2026-08-31 | Code: M (Exercise of derivative) Shares: -13,425 | Price: $0.00 Shares Owned After: 67,120 | Ownership: D (Direct) Footnotes: [F1] Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. [F4] Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. [F4] Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) Footnotes: [F3] Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse. --- Footnotes (Complete Index) --- F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2: Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person. F3: Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse. F4: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. --- Signature --- /s/ /s/ Jim Schindler, as Attorney-in-Fact (2026-09-02)

keid analysis is for reference only and does not constitute investment advice.